Question 1

Does EP Wealth Advisors own ARWR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, EP Wealth Advisors holds 38,135 shares of ARWR (Arrowhead Pharmaceuticals), worth $3.1M.

Question 2

How many shares of ARWR does EP Wealth Advisors own?

Accepted Answer

As of its Q2 2026 13F, EP Wealth Advisors holds 38,135 shares of ARWR (Arrowhead Pharmaceuticals).

Question 3

What is EP Wealth Advisors' ARWR position worth?

Accepted Answer

As of its Q2 2026 13F, EP Wealth Advisors' ARWR position is worth $3.1M.

Question 4

Is EP Wealth Advisors buying or selling ARWR?

Accepted Answer

In Q2 2026, EP Wealth Advisors reduced its ARWR position by 271 shares (-0.7%).

Question 5

When did EP Wealth Advisors first buy ARWR?

Accepted Answer

EP Wealth Advisors first reported ARWR in its Q4 2022 13F and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	38,135	-0.7%	$3.1M	0.0%	$81.51	0
2026-Q1	Decreased	38,406	-0.7%	$2.4M	0.0%	$62.70	0
2025-Q4	Increased	38,683	+0.4%	$2.6M	0.0%	$66.39	26
2025-Q2	New	38,524	—	$608,679	0.0%	$15.80	34
2024-Q3	Exited	0	-100.0%	$0	0.0%	$19.37	0